Vivan Therapeutics Announces the Appointment of Lilly Wollman to Its Board of Directors prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Vivan Therapeutics Announces the Appointment of Lilly Wollman to Its Board of Directors
My Personal Therapeutics Ltd. (trading as
Vivan Therapeutics), a global leader in personalised cancer therapeutics and in-vivo high throughput drug screening, is pleased to announce the addition of
Lilly Wollman to its distinguished board of directors.
Lilly Wollman is a seasoned team-builder and entrepreneurial leader with a 20-year track record in finance and investing. Currently, she is pursuing an MPhil in Computational Biology from the University of Cambridge and is dedicated to a second career solving complex problems in human health through the application of data science and machine intelligence. She is currently a research intern in the CRUK Early Detection Programme, and at the Milner Therapeutics Institute.